Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × Gefitinib × Clear all

NCT00265070 2013-02-05

Trial of Iressa in Prostate Cancer Patients

Phase 2 Completed

Prostatic Neoplasms

NCT00241475 2009-04-23

Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy

Phase 2 Completed

Prostatic Neoplasms

NCT00635856 2009-04-23

Open Label Trial to Assess Iressa in Prostate Cancer Patients

Phase 2 Completed

Prostatic Neoplasms